BFM
IMUX icon

Boothbay Fund Management’s Immunic IMUX Stock Holding History

Boothbay Fund Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,059
Closed -$69.7K – 2255
2025
Q4 		$69.7K Sell
13,059
-11,028
-46% -$80.8K ﹤0.01% 1788
2025
Q3 		$212K Hold
24,087
– – ﹤0.01% 1623
2025
Q2 		$168K Hold
24,087
– – ﹤0.01% 1271
2025
Q1 		$263K Sell
24,087
-18,444
-43% -$199K 0.01% 1094
2024
Q4 		$425K Buy
42,531
+179
+0.4% +$2.25K 0.01% 935
2024
Q3 		$699K Hold
42,352
– – 0.02% 870
2024
Q2 		$470K Hold
42,352
– – 0.01% 1010
2024
Q1 		$559K Buy
42,352
+34,243
+422% +$445K 0.01% 968
2023
Q4 		$122K Hold
8,109
– – ﹤0.01% 1409
2023
Q3 		$119K Sell
8,109
-3,604
-31% -$69.3K ﹤0.01% 1530
2023
Q2 		$294K Hold
11,713
– – 0.01% 1313
2023
Q1 		$175K Hold
11,713
– – ﹤0.01% 1785
2022
Q4 		$164K Buy
+11,713
New +$319K ﹤0.01% 1666
2022
Q3 		– Sell
-1,783
Closed -$62K – 2405
2022
Q2 		$62K Buy
+1,783
New +$114K ﹤0.01% 2057
2021
Q4 		– Sell
-1,747
Closed -$155K – 2019
2021
Q3 		$155K Buy
+1,747
New +$172K ﹤0.01% 1659
2019
Q1 		– Sell
-65
Closed -$5K – 806
2018
Q4 		$5K Buy
65
+38
+141% +$4.45K ﹤0.01% 628
2018
Q3 		$3K Buy
+27
New +$70.5K ﹤0.01% 764

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Boothbay Fund Management's IMUX Position: Q1 2026 in Review

Boothbay Fund Management sold out of Immunic (IMUX) in Q1 2026, closing a stake of 13,059 shares — an estimated $69.7K sold.

Boothbay Fund Management first reported a position in IMUX in Q3 2018 and held it in 17 quarters. The position peaked at $699K in Q3 2024. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Boothbay Fund Management reported no remaining Immunic position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 13,059 Immunic shares in Q1 2026, an estimated $69.7K.
  • Boothbay Fund Management first reported a position in Immunic in Q3 2018 and held it in 17 quarters.
  • Boothbay Fund Management's Immunic position peaked at $699K in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.